The Triple Adipose-Derived Stem Cell Exosome Technology as a Potential Tool for Treating Triple-Negative Breast Cancer.

Andrea PaganiDominik DuscherSebastian Geis Silvan KleinLeonard KnoedlerAdriana C PanayiDmytro OliinykOliver Felthaus Lukas Prantl

Published in: Cells (2024)

The possibility of impacting triple-negative breast cancer cells with engineered Adipose-Derived Stem Cell Exosomes is real. The opportunity to translate our current in vitro analyses into a future in vivo scenario is even more challenging.

Keyphrases

stem cells
breast cancer cells
cell therapy
current status
mesenchymal stem cells
human health
risk assessment
climate change
bone marrow